Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 29Lymphoid 26Breast 14Gastrointestinal 10Tumor-Agnostic 9Plasma cell 7Thoracic 6Myeloid 5Dermatologic 4Head & Neck 3Gynecologic 3Classical hematology 2NET 1Genitourinary 1Endocrine 1CNS 1

Conditions

Neuroendocrine Tumors 145Carcinoma, Neuroendocrine 56Thyroid Cancer, Papillary 54Pheochromocytoma 50Thyroid Neoplasms 41Paraganglioma 41Pituitary Neoplasms 37Adrenocortical Carcinoma 31Neoplasms 30Multiple Endocrine Neoplasia Type 1 30Gastro-enteropancreatic neuroendocrine tumor 29Thyroid Carcinoma, Anaplastic 23Small Cell Lung Carcinoma 21Lung Neoplasms 21Carcinoid Tumor 20Sarcoma 19Breast Neoplasms 19Neoplasm Metastasis 18Carcinoma, Non-Small-Cell Lung 18Carcinoma, Hepatocellular 18Adenoma, Islet Cell 18Melanoma 17Prostatic Neoplasms 15Pancreatic Neoplasms 15Ovarian Neoplasms 15Neuroblastoma 15Colorectal Neoplasms 15Carcinoma, Renal Cell 15Adrenal Gland Neoplasms 15Adenocarcinoma, Follicular 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm, Residual × Endocrine × 1 year × Clear all
NCT05196087 2025-07-02

NIP IT!

University Health Network, Toronto

Recruiting
500 enrolled
BreastDermatologicEndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Breast Neoplasms, Melanoma, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡